Site navigation

Navigation

Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (review)

Irinotecan, oxaliplatin and raltitrexed for advanced colorectal cancer (review of TA33)

Summary

Irinotecan and oxaliplatin are recommended as possible treatments for people with advanced colorectal cancer, if they are used in these ways: irinotecan is given with 5-fluorouracil and folinic acid to people who have not had chemotherapy for advanced colorectal cancer before, or given on its ow ...

Read the complete summary


This guidance replaces TA33 Colorectal cancer (advanced) – irinotecan, oxaliplatin and raltitrexed.


Guidance documents

Implementing this guidance

  • No documents found

We will consult on our review plans for this guidance in August 2008

About this guidance

Technology appraisals TA93

Issued: August 2005

See related guidance:

See this guidance in practice:

Order printed copies of this guidance